April 7 (Reuters) - Viatris VTRS.O said on Monday it would pay up to a maximum of $335 million over nine years as part of a nationwide settlement to resolve opioid-related claims against the drugmaker.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.